CompanyDeals

PackGene Secures Series C Financing to Boost AAV Innovation and Global Expansion

CompanyDeals

Bioworkshops Secures RMB 100 Million in Series A Financing for Biologic Drug Development

CompanyMedical Device

Sinovation Medical’s SinoLITT System and Fiber Kit Gain NMPA Approval for Epilepsy Treatment

CompanyR&D

Merck and XtalPi Leverage Molecular Dynamics to Enhance Small-Molecule Crystallization

CompanyDrug

Neurophth Biotechnology Receives NMPA Approval for Phase I/II Gene Therapy Study

CompanyDeals

Shenzhen Core Medical Technology Secures RMB 200 Million in Series C+ Financing for Artificial Heart Tech

CompanyDrug

Hainan Poly Pharm Wins Health Canada Approval for Generic Cytovene-IV (Ganciclovir)

CompanyDeals

Zephyrm Bioscience Secures Over RMB 200 Million in Series B Financing for Stem-Cell Drug Development

CompanyDeals

Legend Biotech and Janssen Partner with Novartis on Carvykti Manufacturing and Clinical Supply

CompanyDrug

CanSino Biologics Receives NMPA Approval for Bivalent COVID-19 mRNA Vaccine

CompanyDrug

JS InnoPharm Initiates Phase Ib Study of AURKA Inhibitor VIC-1911 for EGFR-TKI Resistant NSCLC

Company

Simcere Pharmaceutical Group Reports 26.4% YOY Revenue Growth in 2022 Financials